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Abstract 
HIV infection is a multiorgan disease with the kidney not spared.  A variety of renal syndromes with varying clinical 
presentations has been reported amongst HIV infected patients. This study aims to highlight the spectrum of clinical presentations 
in HIV infected patients with renal disease. HIV infected patients presenting at University of Benin Teaching Hospital (UBTH) 
Benin City were the study population. A total of 383 patients were studied. Their biodata, clinical presentations and laboratory 
investigations including serum urea, creatinine and albumin, urine protein and creatinine were assessed.  Their glomerular 
filtration rate (GFR) and protein urine excretion were calculated using six equations of modification of diet in renal disease 
(MDRD) and protein: creatinine ratio respectively. Patients were stratified according to their renal functions into normal, mild, 
moderate and severe renal function impairment. The data was analysed using statistical software program SPSS Vs 15.0.  53.3% 
of 383 patients screened had renal function impairment, 40.2% mild, 37.7% moderate and 22.2% severe impairment. Mean age 
was 35.68.3, 36.09.9 and 36.38.3 years for mild, moderate and severe renal function impairment (RFI) respectively. Easy 
fatigability was the commonest symptoms occurring in 47.5%, 30.0%, 37.5% and 22.5% of control, mild RFI, moderate RFI and 
severe RFI subjects respectively (p = 0.568).  Oliguria, facial and body swelling occurred more in patients with RFI especially in 
patients with severe renal impairment. The difference is statistically significant (p = 0.046, 0.041, and 0.033 respectively). Pallor 
was the commonest clinical sign occurring in 32.5%, 50.0%, 35.0% and 62.5% of control and patients with mild, moderate, and 
severe RFI respectively; the difference was not statistically significant (p = 0.459).  Ascites, facial puffiness and pedal oedema 
were commoner in patients with RFI especially those with severe RFI. The differences were statistically significant. (p = 0.048, 
0.019, and 0.008 respectively). In conclusion spectrum of clinical presentations in HIV patients with renal impairment are many 
but few are specific to these patients.   
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Introduction 
 
In 1984, Rao et al reported that renal lesions were found in HIV infected patients. They further described a 
glomerulopathy, which was characterised by heavy proteinuria, biochemical features of nephrotic syndrome, renal impairment 
that rapidly progressed to end stage renal disease (Rao et al., 1984). Males and young adults are more commonly affected 
(Szczech et al., 2004), but nephropathy has been demonstrated in all subsets of HIV infected patients regardless of age, sex, race, 
and mode of HIV acquisition (Nuermberger, 2007). 
 Various presentations have been reported in these patients, varying from asymptomatic proteinuria to End Stage Renal 
Disease (ESRD) with different features of uraemia (Nochy et al., 1993; Winston and Klotman 1996; Seney et al., 1990; Weiner et 
al., 2002).  Urinary abnormalities including oliguria, haematuria, and proteinuria has been reported as presentations in HIV 
patients with impaired renal function (Moro and Sidhartha 2006; Ijoma, 1996).  Extremities oedema and hypertension are not 
common in these patients but some studies have documented them as clinical presentations of renal impairment in HIV patients 
especially in patients without HIV associated nephropathy (i.e. non-HIVAN) and acute renal failure (Franceschini et al., 2004; 
Ruldolph, 2003). Uraemia with its various presentations occur in these patients especially in those with severe renal functional 
impairment (Iglesias et al., 2006).   
There are few studies on the clinical features of HIV patients with renal impairment. This study aims to highlight the 
spectrum of clinical presentations of HIV infected patients with renal disease. 
 
 
Subjects and Method 
 
This is a cross sectional study. Three hundred and eighty three HIV seropositive patients presenting at University of 
Benin Teaching Hospital (out/inpatients) from 1st January 2007 to 30th June 2007 were randomly selected, and screened for renal 
function impairment (RFI) using glomerular filtration rate (GFR) which was calculated by using six variable of Modification of 
Diet in Renal Disease (MDRD) equation. and urine protein excretion using spot urine protein creatinine ratio (PCR). Two 
hundred and four (53.3%) patients among the total screened had RFI detected by GFR < 60ml/min/1.73m2 or PCR  200. They 
were stratified into mild (GFR  60ml/min/1.73m2 but PCR  200), moderate (GFR 30 to 59ml/min/1.73m2) and severe (GFR < 
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30ml/min/1.73ml/min/1.73m2) RFI. Eighty two patients (40.2%), 77 patients (37.7%) and 45 patients (22.2%) had mild, moderate 
and severe RFI respectively. Forty patients were recruited from each stratum by simple random sampling as subjects for the study.  
Forty patients were also recruited as control by simple random sampling from those patients with normal renal functions detected 
by GFR >60ml/min/1.73m2 and PCR < 200.  
Ethical clearance was obtained from the ethical committee of the hospital. The study was explained to the subjects and 
control. Consent was obtained from each subject and control before the study. The data obtained from subjects and control was 
documented. 
The data was analysed using statistical package SPSS Vs 15.0. The frequency distributions of demographic variables 
were computed. A one way analysis of variance (ANOVA) was used to test the comparative analysis of clinical presentations as 
they vary with the severity of RFI. P value < 0.05 was considered significant. 
 
 
Results 
 
Two hundred and four (204) of the three hundred and eighty three (383) HIV infected patients screened constituting 
53.3% had renal function impairment (RFI). Male constitute 61.7% of patients with renal impairment. The distribution of various 
severity of RFI is shown in Table 1 below. 
 
Table 1: Distribution of severity of RFI 
Severity of RFI Number Percent 
Mild 82 40.2 
Moderate 77 37.7 
Severe 45 22.2 
Total 204 100 
 
 
Age distribution 
 
Figure 1 shows the mean age distribution of patients with various severities of RFI and control. Patients with mild RFI 
were younger with mean age of 35.68.3years but patients with moderate and severe RFI had mean age of 36.09.9 and 36.38.3 
years respectively. There was no statistically significant difference between them (p = 0.95). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Mean age of subjects with renal impairment and control groups 
Control – GFR 60ml/min/1.73m2 & PCR < 200mg/g ; Mild - GFR 60ml/min/1.73m2 and PCR 200mg/g 
Moderate – GFR 30 – 59ml/min/1.73m2; Severe – GFR <30ml/min/1.73m2 
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Clinical features 
 
Table 2 shows the major complaints of the subjects and control. Easy fatigability was the commonest symptoms 
occurring in 19 (47.5%), 12 (30.0%), 15 (37.5%) and 9 (22.5%) of control, mild RFI, moderate RFI and severe RFI subjects 
respectively. This was not statistically significant (P = 0.568).  Nausea and vomiting were commonest in patients with severe RFI 
occurring in 10(25.0%) and 16(40.0%) of these patients respectively but they were not statistically significant. Oliguria, facial and 
body swelling also occurred more in patients with RFI especially those with severe renal impairment. The difference was 
statistically significant (p = 0.046, 0.041, and 0.033 respectively). Pruritus was a commoner symptom in control but the difference 
was not statistically significant (P = 0.323).  
 The major clinical findings in patients with various stages of RFI and control were detailed in Table 3. Pallor was the 
commonest signs occurring in 13 (32.5%), 20(50.0%), 14(35.0%) and 25(62.5%) of control and patients with mild, moderate, and 
severe RFI respectively. This was not statistically significant (P= 0.459).  Impaired conscious state, fluffy hair, hepatomegaly, 
splenomegaly, and jaundice were commoner in patients with severe RFI but the differences were not statistically significant. 
Ascites, facial puffiness and pedal oedema were commoner in patients with RFI especially those with severe RFI. The differences 
were statistically significant (P = 0.048, 0.019, and 0.008 respectively). The mean systolic and diastolic blood pressure, and body 
mass index (BMI) were within normal range in both control and subjects.  
 
 
 
Table 2: Symptoms in groups of subjects and control 
SYMPTOMS CONTROL 
N = 40 (%) 
MILD 
N=40(%) 
MODERATE           
N = 40 (%) 
SEVERE 
N=40 (%) 
P VALUE 
Easy fatiguability 19 (47.5) 12 (30.0) 15 (37.5) 9 (22.5) 0.568 
Weakness of the 
body 
13 (32.5) 9 (22.5) 10 (25.0) 12 (30.0) 0.089 
Nausea 9 (22.5) 8 (20.0) 6 (15.0) 10 (25.0) 0.093 
Vomiting  5 (12.5) 2 (5.0) 6 (15.0) 16 (40.0) 0.067 
Pruritus 12 (30.0) 5 (12.5) 7 (17.5) 2 (5.0) 0.323 
Leg swelling 2 (5.0) 3 (7.5) 1 (2.5) 15 (37.5) 0.056 
Polyuria  5 (12.5) 3 (7.5) 3 (7.5) 3 (7.5) 0.125 
Nocturia   4 (10.0) 4 (10.0) 2 (5.0) 4 (10.0) 0.098 
Oliguria 1 (2.5) 1 (2.5) 3 (7.5) 7 (17.5) 0.046* 
Facial swelling 1 (2.5) 0 (0.0) 1 (2.5) 8 (20.0) 0.041* 
Abdominal swelling 0 (0.0) 2 (5.0) 0 (0.0) 5 (12.5) 0.033* 
Loss of 
consciousness  
4 (10.0) 1 (2.5) 0 (0.0) 2 (5.0) 0.254 
Haematuria  3 (7.5) 0 (0.0) 1 (2.5) 1 (2.5) 0.098 
 
 
Table 3: signs in groups of subjects 
SIGNS CONTROL 
N = 40 (%) 
MILD 
N = 40 (%) 
MODERATE 
N = 40 (%) 
SEVERE 
N = 40 (%) 
P VALUE 
Pallor  13 (32.5) 20 (50.0) 14 (35.0) 25 (62.5) 0.459 
Impaired 
consciousness 
0 (0.0) 8 (20.0) 8 (20.0) 14 (35.0) 0.051 
Fever  1 (2.5) 5 (12.5) 7 (17.5) 6 (15.0) 0.086 
Fluffy hair 3 (7.5) 7 (17.5) 1 (2.5) 7 (17.5) 0.061 
Hepatomegaly  1 (2.5) 2 (10.0) 1 (2.5) 8 (20.0) 0.056 
Ascites 0 (0.0) 3 (7.5) 0 (0.0) 6 (15.0) 0.048* 
Splenomegaly  0 (0.0) 1 (2.5) 0 (0.0) 5 (12.5) 0.056 
Facial puffiness 0 (0.0) 0 (0.0) 2(5.0) 3 (7.5) 0.019* 
Jaundice  0 (0.0) 0 (0.0) 1 (2.5) 1 (2.5) 0.054 
Asterexis  1 (2.5) 0 (0.0) 0 (0.0) 1 (2.5) 0.128 
 Pedal oedema 0 (0.0) 1(2.5) 2 (5.0) 3 (7.5) 0.008* 
 Mean systolic BP 
(mmHg) 
115.3317.17 109.6417.08 112.1111.23 118.0019.34 0.912 
 Mean diastolic BP 
(mmHg) 
72.3314.31 74.1912.21 68.1510.15 72.5221.15 0.578 
 Mean BMI 20.134.31 23.96.9 22.78.8 20.044.4 0.652 
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Discussion 
 
 Renal disorder is a common manifestation in HIV infection. The occurrence rate of 53.3% HIV patients with renal 
impairment reported in this study is high when compared to other studies (Jones et al., 2007, Ham et al., 2006). However, Agaba 
in North Central Nigeria reported a prevalence rate of 52%, which compares with this study (Agaba et al., 2003). The mean age of 
about 36 years and predominant male sex in this study is consistent with other studies (Szczech et al., 2004 ). Renal diseases 
presenting as either acute or chronic renal impairment are characterised by varying degrees of clinical features. This depends on 
the degree of severity of impairment in renal function. In addition, human immunodeficiency virus infection has many and diverse 
clinical presentations. Thus there is overlap of clinical features attributable to both HIV infection and RFI, such features include 
easy fatiguability, weakness of the body, nausea, vomiting, pruritus and impaired conscious state (Ijoma, 1996; Onyemelukwe and 
Musa, 2002; Oyediran and Akinkugbe, 1970).  This compares with this study, which showed no statistical significant difference 
in these symptoms between subjects and control.  
Body swelling manifesting as pedal oedema, facial puffiness and occasionally ascites are characteristics features of 
renal impairment, degree and distribution depends on the type and severity of the renal impairment with facial puffiness as one of 
the earliest presentations of impaired renal function. Various studies reported body swelling as an uncommon presentation in HIV 
patients with renal disease, especially in HIV associated nephropathy (HIVAN) ( D’Agati  and Appel, 1997). This contrast with 
this study where oedema is a common presentation in HIV infected patients with renal impairment especially those with severe 
renal function impairment. This may have resulted from added burden of malnutrition prevalent in our environment especially in 
HIV patients, also hypoalbuminaemia, and vascular abnormality are common in patients with impaired renal function. These 
promote interstitial fluid exudation and thus the oedema formation. In addition, this study included HIV patients with various 
causes and type of renal impairment and not just HIVAN.  This compares with the studies of Agaba et al and Ijoma that reported 
oedema as one of the clinical presentations in HIV patients with renal disease. 
 Urinary symptoms, which include oliguria, polyuria, nocturia, and haematuria, have been reported as common clinical 
presentations in renal impairment depending on the type/cause of renal disorder (Moro and Sidhartha, 2006; Ijoma, 1996; D’Agati 
and Appel, 1997). In this study, oliguria was the only urinary symptoms significantly commoner in patients with RFI. This is 
consistent with study by Ijoma at Enugu Nigeria (Ijoma, 1996). HIV is associated with various other abnormalities independent of 
renal function that affects frequency and characteristics of urine. These include urinary tract infection, biochemical and renal 
tubular abnormalities.   
Hypertension is a common presentation in both acute and chronic renal impairment in non-HIV patients but has been 
reported as uncommon in HIV related renal disorder. The mean diastolic and systolic blood pressure in this study is not elevated. 
The reason for the absence of hypertension is not known. 
 Anaemia, which present as pallor is a common presentation in HIV infection and renal impairment and this was clearly 
shown in this study. The causes of anaemia in both clinical conditions are multifactorial. The co-existence of HIV infection and 
renal impairment worsens the burden of anaemia in these patients in terms of morbidity and mortality (Onyemelukwe and Musa, 
2002;  Horwich et al., 2002). 
 Other clinical presentations such as jaundice, hepatomegaly, and splenomegaly may have resulted from other non-renal 
HIV related or unrelated clinical conditions. Also it is noted that most of the clinical presentations mentioned above were 
common in patients with severe RFI. This is consistent with observations in non HIV patients whose clinical features vary with 
severity of RFI. Furthermore severity of  RFI has an inverse relationship with the level of CD4 cell count, thus severe RFI may be 
coexistent with severe immunosupression with antecedent exposure to renal related risk factors like infections, electrolyte 
abnormality, and drugs (Okafor et al., 2008).  
This study acknowledged some limitations which included absence of renal scan, the cross section nature of the study 
and inability to associate the clinical presentations with various risk factors like low CD4 cell count, drugs, co infections etc 
contributing to RFI. Thus patients with shrunken kidneys, and transient proteinuria may have been included as patients. However 
these may not have influenced the result of the study as the patients in this category will have been categorised as normal or mild 
RFI with unremarkable difference in their clinical presentation. 
In conclusion, renal disease is common in HIV infected patients and clinical presentations are many occurring more in 
severe renal impairment. However, few are specific, thus, use of clinical presentations as the only tool for diagnosis of renal 
impairment in HIV patients are not reliable. This makes a detailed assessment of renal function in all HIV patients at presentation 
imperative.  
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